Nucleotide Sequence of Envelope Protein of Japanese Encephalitis Virus SA₁₄-14-2 Adapted to Vero Cells

Abstract

Live attenuated Japanese encephalitis (JE) virus SA₁₄-14-2 produced in primary dog kidney cells (PDK) was adapted to Vero cells. In an effort to gain insight into the molecular basis of the biological characteristics of the SA₁₄-14-2(Vero) strain, the 1500 nucleotide sequence encoding the envelope (E) gene which possesses major neutralizing epitopes was determined and compared with the sequences of two other attenuated JE virus strains, SA₁₄-14-2(PHK) and SA₁₄-14-2(PDK). The amino acid sequence of the C-terminal region (a.a. 280-500) was found to be identical for all three strains, while the N-terminal region (a.a. 1-279) shows sequence variation. The distribution of mutations in the N-terminal region was nearly the same among the three attenuated strains, suggesting that the N-terminal sequences might be related with virus-host cell specificity. However, it was found that Lys and Val (a.a. 138 and 176, respectively), known to be responsible for attenuation, are still conserved in SA₁₄-14-2(Vero). Animal testing showed that SA₁₄-14-2(Vero) has an attenuation phenotype similar to that of the parent s SA₁₄-14-2(PDK) strain in mice.

Key Words:

• Japanese encephalitis
• Vero cells
• Attenuation
• Vaccine
• Polymerase chain reaction
• Nucleotides